• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ANZ
Click for more information
1.81% $33.11

ANZ Group Holdings Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Financial Services

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ANZ
Ann: IFL: OnePath Custodians settles class action 		09:43 0 36
09:43 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 
ANZ
Ann: ANZ agrees to settle superannuation & Esanda class actions 		09:30 0 26
09:30 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  26 
ANZ
Ann: ANZ acknowledges appeal decision on 2015 Placement 		02/10/24 0 30
Metals & Mining SECTOR NEWS

Dive into Bécancour: watch the latest project updates from Lithium Universe

Read More   right-arrow Created with Sketch.
LU7
04 Oct 2024
LITHIUM UNIVERSE LIMITED
02/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  30 
ANZ
Ann: Update - Notification of buy-back - ANZ 		01/10/24 0 32
01/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  32 
ANZ
Ann: Cleansing Notice 		01/10/24 0 41
01/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  41 
ANZ
Ann: Update - Notification of buy-back - ANZ 		30/09/24 0 31
30/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  31 
ANZ
Ann: Update - Notification of buy-back - ANZ 		27/09/24 0 42
27/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  42 
ANZ
Ann: Update - Notification of buy-back - ANZ 		26/09/24 0 40
26/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  40 

See All Discussions arrow Created with Sketch.

Featured News

NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
(20min delay)
Last
$33.11 		Change
0.590(1.81%) 		Mkt cap ! n/a
Open High Low Value Volume
$32.52 $33.11 $32.52 $195.4K 5.949K

Buyers (Bids)

No. Vol. Price($)
0 50 $32.56
 

Sellers (Offers)

Price($) Vol. No.
$33.11 848 0
Last trade - 11.00am 04/10/2024 (20 minute delay) ?
ANZ (NZSX) Chart

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Buxton Resources Ltd has reported strong drilling results together with remodelling data from its Narryer project in Western Australia
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Solstice Minerals to ramp up drilling campaign at Yarri Gold Project Solstice Minerals (ASX:SLS) shares were up nearly 2.5% in afternoon trades on Friday as it announced drilling plans at Yarri.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

Featured News

NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.